Thermo Fisher lifts annual forecast on boost from COVID-related sales

Go back to Thermo Fisher lifts annual forecast on boost from COVID-related sales

Thermo Fisher Scientific (TMO) PT Raised to $715 at Cowen

October 28, 2021 8:07 AM EDT

Cowen analyst Dan Brennan raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $715.00 (from $696.00) while maintaining an Outperform rating.

The analyst commented, "TMO reported a good 3Q, with COVID testing a big driver along with healthy organic growth ex-COVID of 10%... More